Rasuvo shelf life is 17 months. Otrexup’s is 24 to 33 months (24 for 10/15 mg and 33 for 20/25 mg).
= At least 7 more months before need to be returned or thrown away.
I won't sell any below 4.5, depending upon how quickly we get there, which I'm sure will be a function of the Otrexup sales ramp up, I may change my mind and increase my target further
Rasuvo has an exposed needle which most people hate, and this is not a small thing. Otrexup does not have an exposed needle. Otrexup is also a more reliable device.
Good summation. My only quibble is the part about the Otrexup launch not being gangbusters. I've seen that comment before and frankly don't get it. Here we are only about half a year post-launch and already Otrexup is over 450 scripts a week, nearly half way there for Antares to go profitable. Who expected more than that? I didn't. Once Antares is profitable, the pps will really take off. Otrexup will continue to build, and then the follow up products come on, and their potential is even greater.
I don't believe you don't have a position here. I believe you are STILL trying to talk this down. Good luck with that, that ship has sailed.
It is going a lot higher. It will see $5 again, not this year but probably next year and that is not a long wait for such a huge increase. Thanks to all those who sold me shares under 2, I know your intent was to force margin calls on longs or panic them into selling, but I've seen your show before, and know to buy MORE and in LARGER QUANTITIES the more you try to take it down. Because you took it down so much and held it at 2 for so long, overplaying your hand, I've decided I won't sell you any on the way back up anywhere below 4.5 .... you are going to have to pay up to cover. And you will suffer some gap ups on the way, there will be some pre-market positive surprises to keep you shorts in pain.
That's exactly why I bought more, in greater quantities, each nickel down. Now I have a huge number of shares, but my breakeven is all the way down at 2.35
I initially thought the bottom was going to be 2.5, but when it broke that to the downside, I didn't cry about it, I bought MORE and in GREATER AMOUNTS. When it broke 2, I tripled the amount in my but each nickel down. I was ready for it to go below 1.0 if the shorts were stupid enough to take it there.
Exactly right. Same reason stinkyfart and the other bashers aren't here anymore, their hedge fund employer is switching from short to long.
6 cents a share on a 2 to 5 dollar stock is A LOT, especially when you go from -.25 to +0.06 in one year. The 6 cents coupled with the growth rate would result in a much higher price than today.
If ATRS does indeed earn 6 cents next year, the pe will be much higher than 20X because it will reflect great growth. Other small pharma at ATRS stage that are actually earnings positive sell for much more than 20X pe.
What launch "news"? It's not "news" anymore. So what if it's October, the fact that it's being launch hasn't been news for over a month.